Pure Encapsulations O.N.E. Multivitamin Review

Metafolin is a patented form of L-5-methyltetrahydrofolate (L-5-MTHF) — the active, circulating form of folate your body uses directly, the same class of folate Thorne uses. The point of using it over plain folic acid is that folic acid is a synthetic that must be enzymatically converted before your body can use it, a step many people perform inefficiently (Pietrzik 2010). Metafolin skips that conversion, so it works regardless of your folate genetics. Pairing Metafolin with activated B vitamins in a single capsule is a big part of why O.N.E. ranks as a premium, clinician-grade once-daily rather than a basic one-a-day.

It's a deliberate design choice, and for most people it's the right one. Iron is something most men and post-menopausal women shouldn't supplement, so leaving it low (or out) makes O.N.E. a safe unisex default. Calcium is bulky — you physically can't fit a meaningful calcium dose into a single small capsule — and most people get reasonable calcium from food (dairy, leafy greens) anyway, so Pure Encapsulations chose to rely on diet for it rather than bloat the capsule. The catch: if you have diagnosed iron-deficiency or genuinely low calcium intake, O.N.E. won't fix that — you'd need targeted supplements for those specific gaps.

They're genuine bonuses most multivitamins skip. CoQ10 is involved in cellular energy production in the mitochondria, and lutein and zeaxanthin are carotenoids that concentrate in the retina and are associated with eye health. None of them are things a standard multi includes, so getting them bundled into your daily capsule is real added value — particularly the eye carotenoids, which are otherwise a separate purchase. Don't oversell it to yourself: these are supportive extras at modest doses, not therapeutic doses of standalone CoQ10 or eye supplements. But as a 'nice to have it in one pill' addition, they meaningfully differentiate O.N.E. from a plain multivitamin.

Yes — that's the headline feature and it's genuine. O.N.E. (the name is the point) delivers a broad-spectrum, active-form multivitamin in a single daily capsule, where comparable clinician-grade quality usually takes two capsules (Thorne) or even four (whole-food formulas like Garden of Life). The trade-off for fitting everything into one capsule is exactly the low iron and calcium discussed above — those are the bulky nutrients that don't fit. If a single pill is what makes you actually take a multivitamin consistently, O.N.E. is the best once-daily on the list for form quality, with MegaFood One Daily as the whole-food one-tablet alternative.

Keep expectations grounded. O.N.E. is a high-quality multivitamin, but 'clinician-grade' doesn't change what a multivitamin fundamentally is or does — the largest trials found a modest cancer-incidence reduction and no cardiovascular benefit over many years (Gaziano 2012; Sesso 2012), with an emerging cognition benefit in older adults (Baker 2022). What O.N.E. genuinely does is fill your everyday dietary gaps with superior forms, plus throw in some antioxidants, all in one convenient capsule. That's worthwhile insurance, especially if you value the active folate and the once-daily convenience. It is not a longevity intervention, and the bonus CoQ10/lutein are supportive extras, not treatments.

1. [1] Pietrzik 2010 PMID 20608755 — Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Methylfolate (the form Metafolin supplies) is the active, circulating folate usable without enzymatic conversion, unlike folic acid. The basis for crediting O.N.E.'s Metafolin as a genuine bioavailability advantage.
2. [2] Gaziano 2012 (PHS II — cancer) PMID 23162860 — Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. 14,641 participants, 11.2 years: a modest 8% reduction in total cancer incidence. Cited to keep O.N.E.'s upside honest — a small long-run signal, not a longevity claim, even for a premium formula.
3. [3] Sesso 2012 (PHS II — cardiovascular) PMID 23117775 — Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. Same cohort: NO cardiovascular benefit. The null behind the framing — even a premium clinician-grade multivitamin is gap-insurance, not a heart or longevity drug.